NCT01503541View on ClinicalTrials.gov

S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin

CompletedOBSERVATIONAL
Enrollment

365

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Leukemia
Interventions
GENETIC

DNA analysis

GENETIC

RNA analysis

GENETIC

gene expression analysis

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT01503541 - S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin | Biotech Hunter | Biotech Hunter